Literature DB >> 24788226

The C-terminus of tau protein plays an important role in its stability and toxicity.

Junhua Geng1,2, Lu Xia1,2, Wanjie Li1,2, Fei Dou3,4,5.   

Abstract

The identification of tau fragments generated by proteolysis in the neurons of AD patients and in neurofibrillary tangles encourages research on the toxicity of truncated tau. However, the detailed mechanism underlying the proteolysis-induced toxicity of tau is not clear and even controversial in some cases. In the present study, we used Drosophila as a model to evaluate the toxicity of a set of truncated tau fragments in vivo and found that the flies harboring C-terminal-truncated tau exhibited less toxicity due to the unstable characteristic of C-terminal-truncated tau fragments. Further study carried out in cultured Drosophila Kc cells revealed that C-terminal-truncated tau fragments degrade faster than full-length tau or N-terminal-truncated fragments. Collectively, our data implicate proteolysis of tau as an important pathway mediating tau degradation and neurotoxicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788226     DOI: 10.1007/s12031-014-0314-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  40 in total

1.  PHF and PHF-like fibrils--cause or consequence?

Authors:  Y Ihara
Journal:  Neurobiol Aging       Date:  2001 Jan-Feb       Impact factor: 4.673

2.  Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.

Authors:  A Kenessey; P Nacharaju; L W Ko; S H Yen
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

3.  Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.

Authors:  E Bednarski; G Lynch
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

Review 4.  The power and richness of modelling tauopathies in Drosophila.

Authors:  Katerina Papanikolopoulou; Efthimios M C Skoulakis
Journal:  Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.590

5.  Antisense reduction of tau in adult mice protects against seizures.

Authors:  Sarah L DeVos; Dustin K Goncharoff; Guo Chen; Carey S Kebodeaux; Kaoru Yamada; Floy R Stewart; Dorothy R Schuler; Susan E Maloney; David F Wozniak; Frank Rigo; C Frank Bennett; John R Cirrito; David M Holtzman; Timothy M Miller
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

6.  A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

7.  Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.

Authors:  Angela L Guillozet-Bongaarts; Michael E Cahill; Vincent L Cryns; Matthew R Reynolds; Robert W Berry; Lester I Binder
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

8.  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Authors:  Erik D Roberson; Kimberly Scearce-Levie; Jorge J Palop; Fengrong Yan; Irene H Cheng; Tiffany Wu; Hilary Gerstein; Gui-Qiu Yu; Lennart Mucke
Journal:  Science       Date:  2007-05-04       Impact factor: 47.728

9.  An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.

Authors:  Parvoneh Poorkaj; Nancy A Muma; Victoria Zhukareva; Elizabeth J Cochran; Kathleen M Shannon; Howard Hurtig; William C Koller; Thomas D Bird; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

10.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  5 in total

1.  How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Authors:  Liang Xu; Jie Zheng; Martin Margittai; Ruth Nussinov; Buyong Ma
Journal:  ACS Chem Neurosci       Date:  2016-02-24       Impact factor: 4.418

2.  Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.

Authors:  Shotaro Shimonaka; Shin-Ei Matsumoto; Montasir Elahi; Koichi Ishiguro; Masato Hasegawa; Nobutaka Hattori; Yumiko Motoi
Journal:  J Biol Chem       Date:  2020-08-05       Impact factor: 5.157

Review 3.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

4.  Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death.

Authors:  Anne-Laure Bougé; Marie-Laure Parmentier
Journal:  Dis Model Mech       Date:  2016-01-28       Impact factor: 5.758

5.  Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.

Authors:  Junhua Geng; Lu Xia; Wanjie Li; Changqi Zhao; Fei Dou
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.